SCHEMBL1016958

SCHEMBL1016958

CCOC(=O)C(=O)NCc1cccc(-c2ccoc2)c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SERPINE1 P05121 2/20 0.53
MEN1 O00255 5/20 0.40
KMT2A Q03164 5/20 0.40
AOC3 Q16853 2/20 0.40
POLB P06746 2/20 0.40
PPID Q08752 2/20 0.39
CYP1A2 P05177 4/20 0.39
CYP3A4 P08684 4/20 0.39
CYP2D6 P10635 4/20 0.39
MAPT P10636 4/20 0.39
CYP2C19 P33261 4/20 0.39
ALDH1A1 P00352 4/20 0.39
HPGD P15428 4/20 0.39
USP2 O75604 3/20 0.39
HSD17B10 Q99714 3/20 0.39
MAPK1 P28482 3/20 0.39
TSHR P16473 3/20 0.39
KDM4E B2RXH2 2/20 0.39
LMNA P02545 2/20 0.39
HIF1A Q16665 2/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1016040 0.82 SERPINE1 (0.62) SERPINE1MEN1KMT2AAOC3POLB
SCHEMBL12493057 0.82 GPR35 (0.50) MEN1KMT2APOLBPPIDMAPT
SCHEMBL1015834 0.81 CNR1 (0.54) SERPINE1KMT2AMAPTALDH1A1CNR1
SCHEMBL28275382 0.79 SERPINE1 (0.47) SERPINE1AOC3CYP1A2CYP2C19HPGD
SCHEMBL1013779 0.77 SERPINE1 (0.49) SERPINE1AOC3
SCHEMBL1013825 0.76 LMNA (0.52) KMT2AMAPTHPGDMAPK1KDM4E
SCHEMBL17235939 0.76 GPR35 (0.44) MEN1KMT2APOLBPPIDMAPT
SCHEMBL15682692 0.76 RXFP1 (0.53) MEN1KMT2AMAPTTSHRGPR35
SCHEMBL25780269 0.76 EPHX2 (0.49) MAPTALDH1A1MAPK1KDM4ETDP1
SCHEMBL15682690 0.75 KDM4E (0.60) MEN1KMT2ACYP1A2CYP3A4CYP2D6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8415479-B2 Inhibitor of plasminogen activator inhibitor-1 RENASCIENCE CO., LTD. (JP) 2013-04-09 US disclosed
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 RENASCIENCE CO., LTD. (JP) 2011-05-12 US disclosed
EP-2272822-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 Renascience CO., LTD. (JP) 2011-01-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20110112140-A1 INHIBITOR OF PLASMINOGEN ACTIVATOR INHIBITOR-1 SERPINE1, SERPINB1, SERPINC1 SERPINE1 1/4885MEN1 892/4885KMT2A 3970/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.